Clinical trial

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than…

NCT00148252 · University of Oslo School of Pharmacy, Other · Terminated

Key facts

NCT number NCT00148252
Title Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant
Official title Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant - Randomised Withdrawal of Mycophenolate Mofetil (CellCept®) or Cyclosporine A (Sandimmun Neoral®)
Lead sponsor University of Oslo School of Pharmacy, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Renal Transplantation
Intervention type Drug
Interventions Mycophenolate mofetil withdrawal, Cyclosporione A withdrawal
Enrollment 298
Start date Feb 1, 2003
Primary completion Nov 1, 2005
Completion Feb 1, 2007
First posted Sep 7, 2005
Last update posted Jun 7, 2012
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies